VV913 capsules pharmacokinetics safety trial healthy volunteers

ClinicalTrials.gov registered a new Phase 1 clinical trial (NCT07507838) for VV913 capsules, an investigational product being evaluated for pharmacokinetics and safety in healthy adult subjects. The trial is categorized as interventional with a single-group assignment design.

This registration is a routine administrative filing with no compliance deadlines or required actions for external parties. Pharmaceutical companies, clinical investigators, and research institutions should note this trial registration for pipeline monitoring purposes. No penalties or enforcement actions are associated with this registration.